- $8.58bn
- $10.26bn
- $21.53bn
- 93
- 48
- 93
- 92
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 14,035 | 11,264 | 17,361 | 23,446 | 21,529 |
Cost of Revenue | |||||
Gross Profit | 1,127 | 1,443 | 1,849 | 2,400 | 2,314 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13,781 | 10,707 | 16,758 | 22,478 | 20,703 |
Operating Profit | 254 | 558 | 603 | 968 | 827 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 202 | 509 | 522 | 884 | 734 |
Provision for Income Taxes | |||||
Net Income After Taxes | 155 | 386 | 397 | 673 | 557 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 155 | 386 | 397 | 673 | 557 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 155 | 386 | 397 | 673 | 557 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.21 | 13.1 | 15.2 | 28.1 | 25.5 |
Dividends per Share |